Methylprednisolone use in hospitalised COVID-19 patients: a retrospective study
ABSTRACTIntroduction Trials have demonstrated the benefits of methylprednisolone in the treatment of coronavirus disease 2019 (COVID-19). However, data on optimal dose, duration and timing of administration are limited. This study investigates the outcome of various methylprednisolone treatment regi...
Tallennettuna:
Päätekijät: | , , , , |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
Hyllypaikka: |
A1234.567 |
---|---|
Nide 1 | Saatavissa |